A prospective observational registry evaluating clinical outcomes of Radium‐223 treatment in a nonstudy population-Reference-Cited by-同舟云学术

A prospective observational registry evaluating clinical outcomes of Radium‐223 treatment in a nonstudy population

Published:2020-01-21 Issue:4 Volume:147 Page:1143-1151
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Badrising Sushil K.¹^ORCID,Louhanepessy Rebecca D.¹,Noort Vincent²,Coenen Jules L.L.M.³,Hamberg Paul⁴,Beeker Aart⁵,Wagenaar Nils⁶,Lam Marnix G.E.H.⁷,Celik Filiz⁸,Loosveld Olaf J.L.⁹,Oostdijk Ad¹⁰,Zuetenhorst Hanneke⁵,Haanen John B.¹,Vegt Erik¹¹,Zwart Wilbert¹²,Bergman Andries M.¹¹²,

Affiliation:

1. Department of Medical OncologyNetherlands Cancer Institute Amsterdam The Netherlands

2. Department of BiometricsNetherlands Cancer Institute Amsterdam The Netherlands

3. Department of Medical Oncology Isala Zwolle The Netherlands

4. Department of Medical OncologyFranciscus Gasthuis & Vlietland Rotterdam The Netherlands

5. Department of Medical OncologySpaarne Gasthuis Hoofddorp The Netherlands

6. Department of Nuclear MedicineZiekenhuisgroep Twente Hengelo The Netherlands

7. Department of Nuclear MedicineUMC Utrecht Utrecht The Netherlands

8. Department of Nuclear MedicineDeventer Hospital Deventer The Netherlands

9. Department or Medical OncologyAmphia Hospital Breda The Netherlands

10. Department of Nuclear Medicine Isala Zwolle The Netherlands

11. Department of Nuclear MedicineNetherlands Cancer Institute Amsterdam The Netherlands

12. Division of OncogenomicsNetherlands Cancer Institute Amsterdam The Netherlands

Funder

Bayer HealthCare

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32851

Reference29 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer

3. Radionuclide Therapy of Bone Metastases

4. Mechanisms of Bone Metastasis

5. Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increase of prostate-specific antigen doubling time predicts survival in metastatic castration-resistant prostate cancer patients undergoing radium therapy;Annals of Nuclear Medicine;2024-04-22

2. The Impact of Baseline PSMA PET/CT Versus CT on Outcomes of²²³Ra Therapy in Metastatic Castration-Resistant Prostate Cancer Patients;Journal of Nuclear Medicine;2024-02-29

3. Safety and effectiveness of the radium‐223–taxane treatment sequence in patients with metastatic castration‐resistant prostate cancer in a global observational study (REASSURE);Cancer;2024-02-10

4. Increase of prostate specific antigen doubling time predicts survival in metastatic castration-resistant prostate cancer patients undergoing [223Ra]RaCl2 therapy;2023-12-19

5. Bone‐modifying agents are protective for symptomatic skeletal events in Radium‐223 treatment;International Journal of Urology;2023-07-27